A novel perspective on dissemination: somatic metastasis of germ cell tumors from the central nervous system

Shao-Pei Qi1,2, Chuan Zhao1,2,3, Jing-Jing Ge2

  • 1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, China.

Discover Oncology
|June 18, 2025
PubMed
Abstract

Insights

This study introduces a new classification for how central nervous system germ cell tumors (GCTs) spread. Understanding these dissemination patterns can help guide treatment and improve outcomes for this rare cancer.

Area of Science:

  • Neuro-oncology
  • Pathology
  • Medical imaging

Background:

  • Primary germ cell tumors (GCTs) of the central nervous system (CNS) are rare.
  • Somatic metastasis of CNS GCTs is exceptionally uncommon.
  • A novel classification framework for CNS GCT dissemination patterns is proposed.

Purpose of the Study:

  • To propose a novel classification framework for dissemination patterns in CNS GCTs.
  • To analyze the characteristics and spread of rare metastatic CNS GCTs.
  • To provide insights for guiding treatment strategies and improving patient outcomes.

Main Methods:

  • Retrospective analysis of 4 patients with somatic metastasis among 284 CNS GCTs.
  • Clinical history, imaging (radiology), and histopathology (H&E, IHC) were used for characterization.
  • Univariate analysis and Fisher's exact test were employed to analyze spread factors.

Main Results:

  • Identified various metastasis pathways including hematogenous, ventriculoperitoneal shunt, and cerebrospinal fluid spread.
  • Developed a framework for understanding disease spread using concepts like dynamics, components, mediums, ranges, portals, and patterns.
  • One patient died during a 9-67 month follow-up, indicating potential for effective management.

Conclusions:

  • Accurate diagnosis and appropriate treatment are crucial for managing CNS GCTs.
  • The proposed classification framework offers valuable insights for treatment strategies.
  • Understanding dissemination patterns can significantly improve patient outcomes in CNS GCTs.